Literature DB >> 10773729

Uncommon metastasis of a glioblastoma multiforme in liver and spleen.

A Widjaja1, H Mix, C Gölkel, P Flemming, R Egensperger, A Holstein, J Rademaker, H Becker, M Hundt, S Wagner, M P Manns.   

Abstract

A case of a glioblastoma multiforme is presented. Craniotomy was performed with total resection of the right temporal tumor. Postoperatively, the patient received adjuvant radiotherapy, but 6 months after therapy he developed severe nausea and weight loss. Recurrence of an intracranial tumor in the right temporal region with nodules in the liver and spleen were detected by CT scan. Fine-needle biopsies of the liver confirmed the diagnosis of a glioblastoma metastasis with characteristic immunohistochemical staining for glial fibrillary acidic protein. This rare case of an intracerebral glioblastoma metastasizing to liver and spleen was managed by systemic chemotherapy. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10773729     DOI: 10.1159/000007761

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  11 in total

1.  Mediastinal metastasis of glioblastoma multiforme evolving from anaplastic astrocytoma.

Authors:  Hannu Tuominen; Jouni Lohi; Abdel Maiche; Juhani Törmänen; Peter Baumann
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

Review 2.  Metastatic glioblastoma: case presentations and a review of the literature.

Authors:  Gauri Kalokhe; Sean A Grimm; James P Chandler; Irene Helenowski; Alfred Rademaker; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2011-10-02       Impact factor: 4.130

3.  Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategies.

Authors:  Abhishek Ray; Sunil Manjila; Alia M Hdeib; Archana Radhakrishnan; Charles J Nock; Mark L Cohen; Andrew E Sloan
Journal:  Mol Clin Oncol       Date:  2015-01-23

4.  Bone metastases from secondary glioblastoma multiforme: a case report.

Authors:  A Cervio; F Piedimonte; J Salaberry; S C Alcorta; J Salvat; B Diez; G Sevlever
Journal:  J Neurooncol       Date:  2001-04       Impact factor: 4.130

Review 5.  Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment.

Authors:  Wiam El Kheir; Bernard Marcos; Nick Virgilio; Benoit Paquette; Nathalie Faucheux; Marc-Antoine Lauzon
Journal:  Pharmaceutics       Date:  2022-06-01       Impact factor: 6.525

Review 6.  Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.

Authors:  Kanawat Wiwatchaitawee; Juliana C Quarterman; Sean M Geary; Aliasger K Salem
Journal:  AAPS PharmSciTech       Date:  2021-02-11       Impact factor: 4.026

Review 7.  Glioblastoma multiforme - an overview.

Authors:  Kaja Urbańska; Justyna Sokołowska; Maciej Szmidt; Paweł Sysa
Journal:  Contemp Oncol (Pozn)       Date:  2014-08-04

8.  Extra-neural metastases of malignant gliomas: myth or reality?

Authors:  Patrick Beauchesne
Journal:  Cancers (Basel)       Date:  2011-01-27       Impact factor: 6.639

9.  hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements.

Authors:  Rotem Ben-Hamo; Alona Zilberberg; Helit Cohen; Sol Efroni
Journal:  Oncotarget       Date:  2016-04-26

10.  Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.

Authors:  Melissa Umphlett; Stephanie Shea; Jessica Tome-Garcia; Yizhou Zhang; Adilia Hormigo; Mary Fowkes; Nadejda M Tsankova; Raymund L Yong
Journal:  BMC Cancer       Date:  2020-01-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.